7/1/2016-12/31/2016 |
|
Advertising expenses
|
$0.00
|
7/1/2016-12/31/2016 |
|
Photocopies, scans
|
$0.00
|
7/1/2016-12/31/2016 |
|
Computer equipment, supplies
|
$0.00
|
7/1/2016-12/31/2016 |
|
Professional dues
|
$0.00
|
7/1/2016-12/31/2016 |
|
Fax charges
|
$0.00
|
7/1/2016-12/31/2016 |
|
Internet fees
|
$0.00
|
7/1/2016-12/31/2016 |
|
Legal fees
|
$0.00
|
7/1/2016-12/31/2016 |
|
Postage, shipping, delivery
|
$0.00
|
7/1/2016-12/31/2016 |
|
Office supplies, equipment
|
$0.00
|
7/1/2016-12/31/2016 |
|
Printing expenses
|
$0.00
|
7/1/2016-12/31/2016 |
|
Public relations expenses
|
$0.00
|
7/1/2016-12/31/2016 |
|
Rent
|
$0.00
|
7/1/2016-12/31/2016 |
|
Office and support staff salaries
|
$0.00
|
7/1/2016-12/31/2016 |
|
Professional subscriptions
|
$0.00
|
7/1/2016-12/31/2016 |
|
Taxes
|
$0.00
|
7/1/2016-12/31/2016 |
|
Telephone, cell phone, handheld
|
$0.00
|
7/1/2016-12/31/2016 |
|
Utilities (heat, water, electricity)
|
$0.00
|
7/1/2016-12/31/2016 |
|
Other operating expenses
|
$0.00
|
| | Total operating expenses |
$0.00
|
|
Activities, Bill Numbers and Titles
|
|
Client: Novartis Pharmaceuticals Corporation
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $42,000.00
|
House Bill
|
976
|
An Act further regulating the substitution of interchangeable biosimilars
|
Neutral
|
$0.00
|
'N/A'
|
House Bill
|
3418
|
An Act reducing packaging waste in the commonwealth
|
Oppose
|
$0.00
|
'N/A'
|
House Bill
|
800
|
An Act promoting continuity of care for multiple sclerosis treatment
|
Neutral
|
$0.00
|
'N/A'
|
House Bill
|
1894
|
An Act relative to retail pharmacy discounts and co-pay assistance
|
Support
|
$0.00
|
'N/A'
|
House Bill
|
4450
|
An Act Making Appropriations for the Fiscal Year 2017 - Section 110
|
Support
|
$0.00
|
'N/A'
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|